PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.73%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$352M
AUM Growth
+$352M
(+30%)
Cap. Flow
+$77.6M
Cap. Flow
% of AUM
22.07%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
100
New
24
Increased
44
Reduced
21
Closed
11
Top Buys
| 1 |
Boston Scientific
BSX
|
$13.5M |
| 2 |
Eli Lilly
LLY
|
$11.4M |
| 3 |
Edwards Lifesciences
EW
|
$6.77M |
| 4 |
Haemonetics
HAE
|
$6.72M |
| 5 |
CVS Health
CVS
|
$6.11M |
Top Sells
| 1 |
Altimmune
ALT
|
$6.55M |
| 2 |
iRhythm Technologies
IRTC
|
$6.08M |
| 3 |
Avantor
AVTR
|
$5.36M |
| 4 |
908 Devices
MASS
|
$3.07M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.6M |
Sector Composition
| 1 | Healthcare | 96.37% |
| 2 | Industrials | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $17.2M | 4.9% | 82,270 -9,536 | -10% | -$2M |
|
2
UnitedHealth
UNH
$281B
| $14M | 3.97% | 27,641 -1,170 | -4% | -$591K |
|
3
Danaher
DHR
$147B
| $13.7M | 3.89% | 53,006 +14,540 | +38% | +$3.76M |
|
|
4
Boston Scientific
BSX
$156B
| $13.5M | 3.83% | +347,787 | New | +$13.5M |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $12.5M | 3.55% | 117,400 +31,811 | +37% | +$3.38M |
|
|
6
Eli Lilly
LLY
$657B
| $11.4M | 3.24% | +35,285 | New | +$11.4M |
|
|
7
CVS Health
CVS
$92.8B
| $11.2M | 3.19% | 117,634 +64,087 | +120% | +$6.11M |
|
8
Ionis Pharmaceuticals
IONS
$6.79B
| $10.7M | 3.04% | 241,945 +67,645 | +39% | +$2.99M |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.91M | 2.82% | 72,397 -4,229 | -6% | -$579K |
|
|
10
Haemonetics
HAE
$2.63B
| $8.57M | 2.44% | 115,797 +90,797 | +363% | +$6.72M |
|
11
Tenet Healthcare
THC
$16.3B
| $8.2M | 2.33% | 159,024 +66,834 | +72% | +$3.45M |
|
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $8.04M | 2.28% | 222,597 -71,962 | -24% | -$2.6M |
|
13
Elevance Health
ELV
$71.8B
| $7.81M | 2.22% | 17,196 -554 | -3% | -$252K |
|
|
CDMO
14
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.74M | 2.2% | 404,818 -56,408 | -12% | -$1.08M |
|
|
CNCE
15
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $7.62M | 2.17% | 1,137,587 +13,515 | +1% | +$90.6K |
|
16
Waters Corp
WAT
$18B
| $7.45M | 2.12% | 27,630 +1,380 | +5% | +$372K |
|
|
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $7.04M | 2% | 1,210,145 +159,098 | +15% | +$926K |
|
|
18
Edwards Lifesciences
EW
$47.8B
| $6.77M | 1.92% | +81,906 | New | +$6.77M |
|
19
IQVIA
IQV
$32.4B
| $6.37M | 1.81% | 35,171 -4,530 | -11% | -$821K |
|
|
DCPH
20
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.59M | 1.59% | +301,892 | New | +$5.59M |
|
|
RCM
21
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.16M | 1.47% | 278,486 +48,073 | +21% | +$891K |
|
22
Legend Biotech
LEGN
$6.41B
| $4.95M | 1.41% | 121,227 +3,420 | +3% | +$140K |
|
23
Alphatec Holdings
ATEC
$2.35B
| $4.76M | 1.35% | 545,133 +21,398 | +4% | +$187K |
|
24
Natera
NTRA
$23.1B
| $4.61M | 1.31% | 105,201 +31,154 | +42% | +$1.37M |
|
25
Rhythm Pharmaceuticals
RYTM
$6.85B
| $4.61M | 1.31% | +187,989 | New | +$4.61M |
|